Keywords: Hepatic artery embolization; learning curve; hepatocellular carcinoma; operator experience; TAE; Transarterial hepatic embolization; TACE; Transarterial chemoembolization; HCC; Hepatocellular carcinoma; OS; Overall survival; TLP; Time to local tumor progr
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Hepatocellular carcinoma; Nomogram; Time-dependent receiver operating characteristics; Prognostic prediction; ALBI; Albumin-bilirubin; ALT; Alanine transaminase; ANN; Artificial neural network; AST; Aspartate transaminase; BCLC; The Barcelona Clinic Liv
Keywords: Liver Cancer; Screening; Early Detection; Curative Treatment; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; IPCW; inverse probability of censoring weighted; IQR
Keywords: 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: Hepatocellular carcinoma; Overall survival; Disease-free survival; Outcome; Anatomic resection; Parenchyma-sparing; HCC; Hepatocellular carcinoma; AR; Anatomic resection; PSR; Parenchyma-sparing resection; PSA; Propensity score analysis; DFS; Disease-free
Keywords: BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; LR; liver resection; LT; liver transplantation; OS; overall survival;
Keywords: HCC; hepatocellular carcinoma; BCLC; Barcelona-ClÃnic Liver Cancer; HAP; hepaticarterial phase; PVP; portal venous phase; ROC; receiver operating characteristic; AIC; akaike information criteria; OS; overall survival; DFS; disease free survival; TACE; tr
Keywords: BCLC; Barcelona Clinic Liver Cancer; DEE; drug-eluting embolics; HCC; hepatocellular carcinoma; 90Y; yttrium-90;
Keywords: TACE; Transarterial Chemoembolization; cTACE; conventional Transarterial Chemoembolization; HCC; hepatocellular carcinoma; EASL; European Association for the Study of the Liver Guidelines; qEASL; 3D quantitative European Association for the Study of the L
Keywords: ALBI; albumin-bilirubin; BCLC; Barcelona Liver Clinic Cancer; CI; confidence interval; CPC; Child-Pugh class; HCC; hepatocellular carcinoma; N/A; not applicable; PALBI; platelet-bilirubin-albumin; 90Y; yttrium-90;
Keywords: ALT; alanine aminotransferase; BCLC; Barcelona Clinic Liver Cancer; CTCAE; Common Terminology Criteria for Adverse Events; HCC; hepatocellular carcinoma; OR; odds ratio; PES; postembolization syndrome;
Keywords: Liver Cancer; Risk Factors; Prognosis; Predicted Outcome; BCLC; Barcelona Clinic Liver Cancer; ECOG; Eastern Cooperative Oncology Group; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HKLC; Hong Kong Liver Cancer; IAT; intr
Keywords: ALBI; albumin-bilirubin; BCLC; Barcelona Clinic Liver Cancer; C-P; Child-Pugh; CI; confidence interval; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; OS; median overall survival; 90Y; yttrium-90;
Keywords: AASLD; American Association for the Study of Liver Diseases; AFP; alpha-fetoprotein; AIC; Akaike information criterion; AICc; corrected Akaike information criterion; AJCC; American Joint Committee on Cancer; Alk-P; alkaline phosphatase; BCLC; Barcelona Cl
Keywords: 1H NMR; proton nuclear magnetic resonance; AFP; alpha-fetoprotein; ALT; alanine transaminase; BCLC; Barcelona Clinic Liver Cancer; BMI; body mass index; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HIV; human immunodefici
Keywords: BCLC; Barcelona Clinical Liver Cancer; CLDN; claudin; CTC; circulating tumor cell; CSC; cancer stem cells; ECM; extracellular matrix; EGF; epidermal growth factor; EMT; epithelial to mesenchymal transition; FSP-1; fibroblast-specific protein; GANK; gankyr
Keywords: Liver Cancer; BCLC; Early Detection; TherapyAASLD, American Association for the Study of Liver Diseases; AFP, α-fetoprotein; BCLC, Barcelona Clinic Liver Cancer; c-TACE, conventional transarterial chemoembolization; DEB-TACE, transarterial chemoembolizati
Keywords: Liver Cancer; Fatty Liver; NASH; Steatosis; AFP; alpha-fetoprotein; APRI; aspartate aminotransferase to platelet ratio; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; EMR; electronic medical record; HBV; hepatitis B virus; HCC; hepatocellul
Keywords: SBRT; stereotactic body radiation therapy; HCC; hepatocellular carcinoma; RECIST; response evaluation criteria in solid tumors; CTCAE; common terminology criteria for adverse events; LC; local control; OS; overall survival; PFS; progression-free survival;
Keywords: Outcome; Liver Cancer; Therapy; Hepatic; AUROC; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; HAP; hepatic arterial embolization prognostic; HCC; hepatocellular carcinoma; HR; hazard ratio; mHAP; modified hepatic arterial embolization prog
Keywords: HCC; Hepatocellular carcinoma; HBV; Hepatitis B virus infection; HCV; Hepatitis C virus infection; US; Ultrasound; AFP; Alpha-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; RFA; Radiofrequency ablation; TACE; Transarterial chemoembolization; TARE; Tr
Keywords: Liver Cancer; NASH; Incidence; Time; AFP; α-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; CPT; Common Procedural Terminology; EMR; electronic medical records; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepati
Keywords: AFP; α-fetoprotein; AST; aspartate aminotransferase; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; CLIP; Cancer of the Liver Italian Program; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; IQR; interquartile range; PEIT; percutane
Keywords: HCC; hepatocellular carcinoma; TACE; transarterial chemoembolization; AJCC; American Joint Committee on Cancer; BCLC; Barcelona Clinic Liver Cancer; CLIP; Cancer of the Liver Italian Program; JIS; Japan Integrated Staging; CUPI; Chinese University Prognos
Keywords: BCLC; Gadoxetic Acid; Liver Cancer; Combined Image Analyses; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; CT; computed tomography; HCC; hepatocellular carcinoma; HR; hazard ratio; IPTW; inverse probability treatment weighting; MR; magneti
Keywords: BCLC; Barcelona Clinic Liver Classification; CI; confidence interval; HCC; hepatocellular carcinoma; MW; microwave; OS; overall survival; PFS; progression-free survival;
Keywords: AFP; α-fetoprotein; AUC; area under the curve; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; IL; interleukin; mRECIST; modified Response Evaluation Criteria In Solid Tumors; NLR; neutrophil-to-lymphocyte ratio; RE; radioembolization
Keywords: hepatocellular carcinoma (HCC); BCLC; OkudaAJCC, American Joint committee on cancer; BCLC, Barcelona clinic liver cancer; CLIP, cancer of the liver Italian program; CUPI, Chinese University prognostic index; ES, extra-hepatic spread; HCC, hepatocellular c
Keywords: HCC; hepatocellular carcinoma; TTP; time to progression; NTUH; National Taiwan University Hospital; OS; overall survival; BCLC; Barcelona Clinic Liver Cancer; CLIP; Cancer of the Liver Italian Program; ECOG PS; Eastern Cooperative Oncology Group performan
Keywords: BCLC; Barcelona Clinic Liver Cancer; DEB; drug-eluting bead; HCC; hepatocellular carcinoma; MELD; Model for End-stage Liver Disease;
Keywords: HCC; hepatocellular carcinoma; CHB; chronic hepatitis B; PLC; primary liver cancer; HR; hepatic resection; LT; liver transplantation; US; ultrasound; EASL; European Association for the Study of the Liver; EORTC; European Organization for Research and Trea
Keywords: ALT; alanine aminotransferase; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HR; hazard ratio;
Keywords: HCC; hepatocellular carcinoma; RFA; radiofrequency ablation; PEI; percutaneous ethanol injection; TACE; transarterial chemoembolization; BCLC; Barcelona Clinic Liver Cancer; 125I; iodine-125; CT; computed tomography; MR; magnetic resonance; OS; overall su
Keywords: NAFLD; non-alcoholic fatty liver disease; HCC; hepatocellular cancer; CLD; chronic liver disease; BCLC; Barcelona Clinic for Liver Cancer; ALD; alcoholic liver disease; HCV; hepatitis C; HBV; hepatitis B; PBC; primary biliary cirrhosis; AIH; autoimmune he
Keywords: BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; 90Y; yttrium-90;
Keywords: liver cancer; treatment algorithm; BCLC; stagingAJCC–UICC, American Joint Committee on Cancer and Union for International Cancer Control; ALT, alanine aminotransferase; BCLC, Barcelona Clinic Liver Cancer; bm-JIS, biomarker JIS; CEUS, contrast-enhanced ul
Keywords: Hepatocellular carcinoma; Prognosis; BCLC; Staging system
Keywords: BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; LSF; lung shunt fraction; PVT; portal vein thrombosis; ROI; region of interest; SPECT; single photon emission computed tomography; 99mTc-MAA; technetium-99m macroaggregated albumin; TD; t
Keywords: AFP; α-fetoprotein; AIC; Akaike information criterion; BCLC; Barcelona Clinic Liver Cancer; C-index; concordance index; CLIP; Cancer of the Liver Italian Program; CTP; Child-Turcotte-Pugh; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular car
Keywords: BCLC; Barcelona Clinic Liver Cancer; CI; 95% confidence interval; CP; Child-Pugh; CT; computed tomography; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; LRT; locoregional therapy; MRI; magnetic resonance imaging;
Keywords: HCC; hepatocellular carcinoma; RFA; radiofrequency ablation; PEI; percutaneous ethanol injection; TACE; transarterial chemoembolization; BCLC; Barcelona Clinic Liver Cancer; AEs; adverse events; INR; International Normalized Ratio; MELD; Model for End-Sta
Keywords: sCD163; soluble CD163; HCC; hepatocellular carcinoma; OS; overall survival; AFP; alpha-fetoprotein; CLIP; Cancer of the Liver Italian Program; BCLC; Barcelona Clinic Liver Cancer; CRP; C-reactive protein; NASH; non-alcoholic steatohepatitis; CK; cytokerat
Keywords: ADME; absorption distribution metabolism and excretion; AFP; alpha-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; Chk 1; check point 1; HBV; Hepatitis B Virus; HCC; hepatocellular carcinoma; HCV; Hepatitis C Virus; LT; liver transplatation; NAFLD; nona
Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era
Keywords: HCV; hepatitis C virus; HCC; hepatocellular carcinoma; IQR; interquartile range; HR; hazard ratio; AHR; adjusted hazard ratio; CTP; Child-Turcotte-Pugh; PS; performance status; ECOG; Eastern Cooperative Oncology Group; BCLC; Barcelona Clinic Liver Cancer;
Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study
Keywords: Early hepatocellular carcinoma; Microvascular invasion; HBeAg; Hepatectomy; Survival; HCC; hepatocellular carcinoma; TNM; Tumor-Node-Metastasis; BCLC; Barcelona clinic liver cancer; RFS; recurrence-free survival; OS; overall survival; ALT; alanine aminotr
Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching
Keywords: BCLC; Barcelona Clinic Liver Cancer; CTP; Child-Turcotte-Pugh; ECOG; Eastern Cooperative Oncology Group; HCC; heptaocellular carcinoma; MVI; macrovascular invasion; SOR; sorafenib;
Two sides of a coin: GG genotype of C7 provides protection against fibrosis severity while showing a higher risk for hepatocellular carcinoma in patients with hepatitis C
Keywords: CS; Complement System; C7; Complement Component 7; MAC; Membrane Attack Complex; HCC; Hepatocellular Carcinoma; PCR; Polymerase Chain Reaction; OR; Odds Ratio; CI; Confidence Interval; HCV; Hepatitis C Virus; SNP; Single Nucleotide Polymorphism; RNA; Ribo
Role of Indocyanine Green in Predicting Post-Transarterial Chemoembolization Liver Failure in Hepatocellular Carcinoma
Keywords: AUROC; Area Under Receiver Operator Characteristic Curve; BCLC; Barcelona Clinic Liver Cancer; HCC; Hepatocellular Carcinoma; ICG; Indocyanine Green; LF; Liver Failure; MELD; model For End Stage Liver Disease; PDR; Plasma Disappearance Rate; TACE; Trans-a
Expression of zinc transporters ZIP4, ZIP14 and ZnT9 in hepatic carcinogenesis-An immunohistochemical study
Keywords: HCC; hepatocellular carcinoma; AFLD; alcohol-induced fatty liver disease; NAFLD; non-alcoholic fatty liver disease; Vh; viral hepatitis; ZIP; Zrt-Irt-like protein; ZnT; Zinc transporter protein; BCLC; Barcelona Clinic Liver Cancer; Hepatitis; Hepatocellul
Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices
Keywords: ALBI; albumin-bilirubin; ALBI-PLT score; albumin-bilirubin grade and platelet count; BCLC; Barcelona Clinic Liver Cancer; CTP; Child-Turcotte-Pugh; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HRV; high-risk esophageal va